Clinical trial
Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing…
NCT00257868 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00257868 |
|---|---|
| Title | Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery |
| Official title | Rivastigmine for the Prevention of Postoperative Delirium After Cardiac Surgery |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Delirium |
| Intervention type | Drug |
| Interventions | Rivastigmine prevention of delirium |
| Enrollment | 120 |
| Start date | Jan 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Nov 23, 2005 |
| Last update posted | Jul 31, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: